Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,205,091
-
Share change
-
+479,775
-
Total reported value
-
$40,479,753
-
Put/Call ratio
-
83%
-
Price per share
-
$2.85
-
Number of holders
-
65
-
Value change
-
+$2,242,568
-
Number of buys
-
31
-
Number of sells
-
30
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q4 2020
As of 31 Dec 2020,
RECRO PHARMA INC - COM (SCTL) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,205,091 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., Portolan Capital Management, LLC, VANGUARD GROUP INC, Rubric Capital Management LP, MAK CAPITAL ONE LLC, D. E. Shaw & Co., Inc., Alyeska Investment Group, L.P., Newtyn Management, LLC, and Russell Investments Group, Ltd..
This page lists
65
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.